The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer.

Julie Tsu-Yu WuJune CorriganChloe SuClark DumontierJennifer LaAparjita KhanShipra AryaAlex H S HarrisLeah BackhusMillie DasNhan V DoMary T BrophySummer S HanMichael KelleyNathanael R Fillmore

Published in: Cancer immunology, immunotherapy : CII (2024)

Frail patients with both good and poor PS received less intensive treatment. However, frailty has a limited effect on survival among those with poor PS. These findings suggest that PS, not frailty, drives survival on intensive treatment.

Keyphrases

advanced non small cell lung cancer
community dwelling
combination therapy
smoking cessation